Project Synopsis:

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

MarketLines' International Stem Cell Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by International Stem Cell Corporation since January 2007.

Scope:

– Provides intelligence on International Stem Cell Corporation's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
– Detailed reports of various financial transactions undertaken by International Stem Cell Corporation and its subsidiaries since 2007.
– Information about key financial and legal advisors for International Stem Cell Corporation's financial deals transactions.
– Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Highlights:

This report includes International Stem Cell Corporation's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by International Stem Cell Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:

– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
– Form an independent opinion about International Stem Cell Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
– Track your competitors’ business structure and growth strategies.

Table Of Contents

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
CAPITAL RAISING
--Capital Raising - Overview
--Capital Raising - Deal reports
PRIVATE EQUITY and OWNERSHIP
--Private Equity and Ownership - Overview
--Private Equity and Ownership - Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center

LIST OF TABLES

--International Stem Cell Corporation activity by deal type - volume (2010 -YTD2014)
--International Stem Cell Corporation legal advisor ranking by value ($m)
--Top Deals(2010 -YTD2014)
--International Stem Cell Corporation targets and partners (2010 -YTD2014)
--International Stem Cell Corporation partnership volume and value trend (2010-YTD2014)
--International Stem Cell Corporation partnership trend by key deal type (2010-YTD2014)
--International Stem Cell Corporation capital raising volume and value trend (2010-YTD2014)
--International Stem Cell Corporation capital raising by deal type (2010-YTD2014)
--International Stem Cell Corporation private equity and ownership volume and value trend (2010-YTD2014)
--International Stem Cell Corporation private equity and ownership activity by deal type (2010-YTD2014)

LIST OF FIGURES

--International Stem Cell Corporation activity by deal type - volume (2010-YTD2014)
--International Stem Cell Corporation partnership volume and value trend (2010-YTD2014)
--International Stem Cell Corporation partnership trend by key deal type (2010-YTD2014)
--International Stem Cell Corporation capital raising volume and value trend (2010-YTD2014)
--International Stem Cell Corporation capital raising by deal type (2010-YTD2014)
--International Stem Cell Corporation private equity and ownership volume and value trend (2010-YTD2014)
--International Stem Cell Corporation private equity and ownership by deal type (2010-YTD2014)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Degenerative Disc Disease - Pipeline Review, H1 2014

Degenerative Disc Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Degenerative Disc Disease - Pipeline Review, H1 2014', provides an overview of the Degenerative Disc Disease's therapeutic ...

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Critical Limb Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

Bone Regeneration - Pipeline Review, H2 2014

Bone Regeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.